These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34427803)

  • 1. Adjuvant radiotherapy improves overall survival when added to surgery and chemotherapy for uterine carcinosarcoma: a surveillance, epidemiology, and end results analysis.
    Squires BS; Quinn TJ; Nandalur SR; Jawad MS
    Int J Clin Oncol; 2021 Dec; 26(12):2282-2294. PubMed ID: 34427803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Adjuvant Pelvic Radiotherapy on Distant Metastasis for Uterine Carcinosarcoma.
    Eng NL; Rana SR; Hall KL; Eng TY
    Am J Clin Oncol; 2021 Apr; 44(4):169-173. PubMed ID: 33481373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08).
    Cha J; Kim YS; Park W; Kim HJ; Kim JY; Kim JH; Kim J; Yoon WS; Kim JW; Kim YB
    J Gynecol Oncol; 2016 Nov; 27(6):e58. PubMed ID: 27550404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.
    Makker V; Abu-Rustum NR; Alektiar KM; Aghajanian CA; Zhou Q; Iasonos A; Hensley ML
    Gynecol Oncol; 2008 Nov; 111(2):249-54. PubMed ID: 18755503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma.
    Cantrell LA; Havrilesky L; Moore DT; O'Malley D; Liotta M; Secord AA; Nagel CI; Cohn DE; Fader AN; Wallace AH; Rose P; Gehrig PA
    Gynecol Oncol; 2012 Oct; 127(1):22-6. PubMed ID: 22727985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma.
    Clayton Smith D; Kenneth Macdonald O; Gaffney DK
    Radiother Oncol; 2008 Aug; 88(2):227-32. PubMed ID: 18160157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.
    Galaal K; van der Heijden E; Godfrey K; Naik R; Kucukmetin A; Bryant A; Das N; Lopes AD
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006812. PubMed ID: 23450572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of chemotherapy and radiotherapy in the adjuvant management of uterine carcinosarcoma: a population-based analysis.
    Ding L; Bi Z; Wu J; Zhu J; Yu Y; Yao HR; Liu YM
    Arch Gynecol Obstet; 2023 Mar; 307(3):891-901. PubMed ID: 35708782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
    Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
    Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of brachytherapy and external beam radiation therapy for early stage, node-negative uterine carcinosarcoma.
    Patel N; Hegarty SE; Cantrell LA; Mishra MV; Showalter TN
    Brachytherapy; 2015; 14(5):606-12. PubMed ID: 26166579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study.
    Li Y; Ren H; Wang J
    BMC Cancer; 2019 Jul; 19(1):697. PubMed ID: 31307426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiation therapy in uterine carcinosarcoma: A population-based analysis of patient demographic and clinical characteristics, patterns of care and outcomes.
    Manzerova J; Sison CP; Gupta D; Holcomb K; Caputo TA; Parashar B; Nori D; Wernicke AG
    Gynecol Oncol; 2016 May; 141(2):225-230. PubMed ID: 26896827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma.
    Matsuo K; Omatsu K; Ross MS; Johnson MS; Yunokawa M; Klobocista MM; Im DD; Bush SH; Ueda Y; Takano T; Blake EA; Hasegawa K; Baba T; Shida M; Satoh S; Yokoyama T; Machida H; Adachi S; Ikeda Y; Iwasaki K; Miyake TM; Yanai S; Nishimura M; Nagano T; Takekuma M; Takeuchi S; Pejovic T; Shahzad MM; Ueland FR; Kelley JL; Roman LD
    Gynecol Oncol; 2017 Apr; 145(1):78-87. PubMed ID: 28215838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of radiotherapy modalities on outcomes in the adjuvant management of uterine carcinosarcoma: A National Cancer Database analysis.
    Stokes WA; Jones BL; Schefter TE; Fisher CM
    Brachytherapy; 2018; 17(1):194-200. PubMed ID: 29097136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.
    Galaal K; Godfrey K; Naik R; Kucukmetin A; Bryant A
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006812. PubMed ID: 21249682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation.
    Makker V; Kravetz SJ; Gallagher J; Orodel OP; Zhou Q; Iasonos A; DeLair D; Aghajanian C; Hensley ML
    Int J Gynecol Cancer; 2013 Nov; 23(9):1635-41. PubMed ID: 24172099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.
    Garg G; Yee C; Schwartz K; Mutch DG; Morris RT; Powell MA
    Gynecol Oncol; 2014 May; 133(2):242-9. PubMed ID: 24561247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
    Nemani D; Mitra N; Guo M; Lin L
    Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery.
    Matsuo K; Johnson MS; Im DD; Ross MS; Bush SH; Yunokawa M; Blake EA; Takano T; Klobocista MM; Hasegawa K; Ueda Y; Shida M; Baba T; Satoh S; Yokoyama T; Machida H; Ikeda Y; Adachi S; Miyake TM; Iwasaki K; Yanai S; Takeuchi S; Nishimura M; Nagano T; Takekuma M; Shahzad MMK; Pejovic T; Omatsu K; Kelley JL; Ueland FR; Roman LD
    J Surg Oncol; 2018 Mar; 117(3):488-496. PubMed ID: 29044542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma.
    Einstein MH; Klobocista M; Hou JY; Lee S; Mutyala S; Mehta K; Reimers LL; Kuo DY; Huang GS; Goldberg GL
    Gynecol Oncol; 2012 Jan; 124(1):26-30. PubMed ID: 22055846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.